US Patent 7772239 Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists

Patent 7772239 was granted and assigned to Theravance on August, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Theravance

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

77722390

Patent Inventor Names

Seok-ki Choi0

Paul R. Fatheree0

Roland Gendron0

S. Derek Turner0

Adam A. Goldblum0

Daniel D. Long0

Daniel Marquess0

Date of Patent

August 10, 2010

Patent Application Number

119862120

Date Filed

November 20, 2007

Patent Primary Examiner

‌

D. Margaret Seaman

Patent abstract

The invention provides novel benzoimidazolone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7772239 Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API